Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

537
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
537
Angina II: Classification01:27

Angina II: Classification

539
Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
539
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

3.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.9K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

1.3K
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.3K
Angina IV: Management01:26

Angina IV: Management

389
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
389
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

703
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
703

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

In Search of the Perfect Thrombosis and Bleeding-Associated Cancer Scale.

Seminars in thrombosis and hemostasis·2023
Same author

Inflammation and vascular diseases.

Vnitrni lekarstvi·2022
Same author

Diosmin/hesperidin: a cooperating tandem, or is diosmin crucial and hesperidin an inactive ingredient only?

Vnitrni lekarstvi·2020
Same author

Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine.

Thrombosis and haemostasis·2020
Same author

Anticoagulant therapy in the elderly.

Vnitrni lekarstvi·2019
Same author

Erectile Dysfunction in Young Myocardial Infarction Survivors: Evaluation, Follow Up.

American journal of men's health·2017

Related Experiment Video

Updated: Mar 17, 2026

The Arteriovenous AV Loop in a Small Animal Model to Study Angiogenesis and Vascularized Tissue Engineering
08:53

The Arteriovenous AV Loop in a Small Animal Model to Study Angiogenesis and Vascularized Tissue Engineering

Published on: November 2, 2016

13.1K

[Angiology is moving forward].

Debora Karetová

    Casopis Lekaru Ceskych
    |August 3, 2016
    PubMed
    Summary

    Vascular medicine addresses urgent and chronic conditions affecting arteries, veins, and lymphatics. Specialists in vascular medicine provide optimal care through rapid diagnosis and treatment, collaborating with surgeons and radiologists.

    Area of Science:

    • Vascular Medicine
    • Angiology
    • Cardiovascular Diseases

    Background:

    • Vascular medicine encompasses the diagnosis and management of diverse vascular diseases, including ischemic syndromes, venous disorders, and lymphatic conditions.
    • Urgent vascular conditions like aneurysm rupture, acute limb ischemia, deep vein thrombosis, and pulmonary embolism pose life-threatening risks.
    • Chronic vascular diseases, such as peripheral arterial disease and chronic superficial venous disease, necessitate tailored management strategies focusing on prevention and underlying conditions.

    Purpose of the Study:

    • To provide an overview of significant advancements in the field of angiology.
    • To highlight the critical role of vascular medicine specialists in patient care.
    • To emphasize the collaborative approach involving vascular surgeons and interventional radiologists.
    Keywords:
    aortic aneurysmdisease of the carotid arteriesinterdisciplinary approach.thromboembolismvascular medicine

    More Related Videos

    Angiogenesis in the Ischemic Rat Lung
    07:36

    Angiogenesis in the Ischemic Rat Lung

    Published on: February 8, 2013

    16.0K
    Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
    05:58

    Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

    Published on: February 3, 2021

    4.4K

    Related Experiment Videos

    Last Updated: Mar 17, 2026

    The Arteriovenous AV Loop in a Small Animal Model to Study Angiogenesis and Vascularized Tissue Engineering
    08:53

    The Arteriovenous AV Loop in a Small Animal Model to Study Angiogenesis and Vascularized Tissue Engineering

    Published on: November 2, 2016

    13.1K
    Angiogenesis in the Ischemic Rat Lung
    07:36

    Angiogenesis in the Ischemic Rat Lung

    Published on: February 8, 2013

    16.0K
    Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
    05:58

    Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

    Published on: February 3, 2021

    4.4K

    Main Methods:

    • Review of current literature and clinical practices in vascular medicine.
    • Discussion of diagnostic and treatment work-up strategies.
    • Integration of insights from interdisciplinary collaboration.

    Main Results:

    • Identification of key innovations in angiology.
    • Emphasis on the efficiency of vascular specialists in patient management.
    • Recognition of the importance of a multidisciplinary approach for optimal outcomes.

    Conclusions:

    • Vascular medicine is a crucial specialty for managing a wide spectrum of vascular and lymphatic diseases.
    • The rapid and accurate diagnosis and treatment by vascular medicine specialists, in conjunction with surgeons and radiologists, are vital for effective patient care.
    • Continuous innovation in angiology drives improved prevention and treatment of vascular conditions.